Page 164 - Strategies for non-invasive managementof high-grade cervical intraepithelial neoplasia - prognostic biomarkers and immunotherapy Margot Maria Koeneman

Chapter 8
References
1. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. Journal of the National Cancer Institute. 2000;92(9):690-8.
2. Crane JM. Pregnancy outcome after loop electrosurgical excision procedure: a systematic review. Obstetrics and gynecology. 2003;102(5 Pt 1):1058-62.
3. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006;367(9509):489-98.
4. SpracklenCN,HarlandKK,StegmannBJ,SaftlasAF.Cervicalsurgeryforcervicalintraepithelial neoplasia and prolonged time to conception of a live birth: a case-control study. BJOG : an international journal of obstetrics and gynaecology. 2013;120(8):960-5.
5. Grimm C, Polterauer S, Natter C, Rahhal J, Hefler L, Tempfer CB, et al. Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial. Obstetrics and gynecology. 2012;120(1):152-9.
6. Lin CT, Qiu JT, Wang CJ, Chang SD, Tang YH, Wu PJ, et al. Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia. Taiwanese journal of obstetrics & gynecology. 2012;51(4):533-8.
7. de Witte CJ, van de Sande AJ, van Beekhuizen HJ, Koeneman MM, Kruse AJ, Gerestein CG. Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: A review. Gynecologic oncology. 2015;139(2):377-84.
8. Martin-Hirsch PP, Paraskevaidis E, Bryant A, Dickinson HO. Surgery for cervical intraepithelial neoplasia. The Cochrane database of systematic reviews. 2013;12:CD001318.
9. Pachman DR, Barton DL, Clayton AC, McGovern RM, Jefferies JA, Novotny PJ, et al. Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia. American journal of obstetrics and gynecology. 2012;206(1):42 e1-7.
10. Koeneman MM, van de Sande AJ, van Beekhuizen HJ, Gerestein KG, van de Laar R, Kruitwagen RF, et al. Physicians’ Awareness, Attitudes, and Experiences Regarding Imiquimod Treatment of Vaginal and Cervical Intraepithelial Neoplasia. Journal of lower genital tract disease. 2016;20(1):75-9.
11. Amaya-amaya M GK, Ryan M. Using Discrete Choice Experiments to Value Health and Health Care. Heidelberg: Springer; 2008 2008.
12. Group T, Sharp L, Cotton S, Cochran C, Gray N, Little J, et al. After-effects reported by women following colposcopy, cervical biopsies and LLETZ: results from the TOMBOLA trial. BJOG : an international journal of obstetrics and gynaecology. 2009;116(11):1506-14.
13. http://www.choice-metrics.com [accessed 20.10.2013].
14. Reed Johnson F, Lancsar E, Marshall D, Kilambi V, Muhlbacher A, Regier DA, et al. Constructing
experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2013;16(1):3-13.
15. Lantz CA, Nebenzahl E. Behavior and interpretation of the kappa statistic: resolution of the two paradoxes. Journal of clinical epidemiology. 1996;49(4):431-4.
162